Nami Lee
Overview
Explore the profile of Nami Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kim B, Lee J, Jang H, Lee N, Mehta J, Jang S
Adv Ther
. 2022 Aug;
39(10):4757-4771.
PMID: 35962934
Introduction: Lazertinib is an irreversible, mutant-selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Co-administration of TKIs with acid-reducing agents (ARAs) can lead to potential drug-drug interactions, which decreases...
12.
Heo Y, Lee N, Choi S, Jeon J, Han S, Kim D, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625768
Hepatic fibrosis is the excessive production and deposition of the extracellular matrix, resulting in the activation of the fibrogenic phenotype of hepatic stellate cells (HSCs). The Hippo/Yes-associated protein (YAP) signalling...
13.
Seo H, Song G, Ku J, Park H, Myung W, Kim H, et al.
BMC Psychiatry
. 2022 May;
22(1):332.
PMID: 35562709
Background: The psychiatric treatment gap is substantial in Korea, implying barriers in seeking help. Objectives: This study aims to explore barriers of seeing psychiatrists, expressed on the internet by age...
14.
Lee N, Park S, Kang D, Jeon J, Kim H, Kim D, et al.
Diabetes Care
. 2022 Feb;
45(5):1141-1150.
PMID: 35226735
Objective: The natural course of diabetes of the exocrine pancreas (DEP) is not well established. We aimed to compare the risk of insulin initiation, diabetic complications, and mortality between DEP...
15.
Lee N, Heo Y, Choi S, Jeon J, Han S, Kim D, et al.
Biochem Biophys Res Commun
. 2021 Dec;
588:154-160.
PMID: 34971904
Non-alcoholic fatty liver disease (NAFLD) includes a broad spectrum of liver diseases characterized by steatosis, inflammation, and fibrosis. This study aimed to investigate the potential of dipeptidyl peptidase-4 inhibitors and...
16.
Cho B, Han J, Kim S, Lee K, Cho E, Lee Y, et al.
J Thorac Oncol
. 2021 Dec;
17(4):558-567.
PMID: 34958928
Introduction: This integrated analysis of a phase 1/2 study (NCT03046992) evaluated the efficacy and safety of lazertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in patients with advanced EGFR T790M-positive...
17.
Lee D, Hong Y, Seo H, Yun J, Nam S, Lee N
Saf Health Work
. 2021 Sep;
12(3):377-383.
PMID: 34527400
Background: This study investigated the longitudinal associations between the degrees of positive and negative spillover in work-life balance (WLB) at baseline and reports of depressive mood at a 2-year follow-up...
18.
Nam S, Lee D, Seo H, Hong Y, Yun J, Cho S, et al.
Psychiatry Investig
. 2021 Aug;
18(8):770-778.
PMID: 34404121
Objective: The current study examined the differential empathic capacity, post-traumatic symptoms, and coping strategies in healthcare workers (HCWs) according to the exposure of verbal or physical workplace violence (WPV). Methods:...
19.
Lee N, Heo Y, Choi S, Jeon J, Han S, Kim D, et al.
J Immunol Res
. 2021 Jun;
2021:9944880.
PMID: 34124273
Background: Sodium-glucose cotransporter 2 (SGLT2) and dipeptidyl peptidase-4 (DPP-4) inhibitors are glucose-lowering drugs whose anti-inflammatory properties have recently become useful in tackling metabolic syndromes in chronic inflammatory diseases, including diabetes...
20.
Heo Y, Choi S, Lee N, Jeon J, Han S, Kim D, et al.
J Gastroenterol Hepatol
. 2021 Feb;
36(9):2592-2600.
PMID: 33600604
Background And Aim: Non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to non-alcoholic steatohepatitis, which is characterized by hepatic inflammation that can progress to fibrosis, cirrhosis, and hepatocellular carcinoma....